1. A New Standard of Care: Pembrolizumab in Programmed Death-ligand 1 Positive, Metastatic, Triple-negative Breast Cancer. Issue 2 (2021) Authors: Johnson, Kai CC; Wesolowski, Robert; Gatti-Mays, Margaret E Journal: Touch reviews in oncology & haematology Issue: Volume 17:Issue 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Treatment of small (T1mic, T1a, and T1b) node-negative HER2+ breast cancer – a review of current evidence for and against the use of anti-HER2 treatment regimens. Issue 5 (4th May 2022) Authors: Johnson, Kai CC; Quiroga, Dionisia; Sudheendra, Preeti; Wesolowski, Robert Journal: Expert review of anticancer therapy Issue: Volume 22:Issue 5(2022) Page Start: 505 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗